Check-Cap Ltd. (CHEK)

USD 0.6

(-0.84%)

Total Debt Summary of Check-Cap Ltd.

  • Check-Cap Ltd.'s latest annual total debt in 2023 was - USD , down -100.0% from previous year.
  • Check-Cap Ltd.'s latest quarterly total debt in 2023 FY was - USD , down -100.0% from previous quarter.
  • Check-Cap Ltd. reported annual total debt of 964 Thousand USD in 2022, down -15.81% from previous year.
  • Check-Cap Ltd. reported annual total debt of 1.14 Million USD in 2021, up 194.34% from previous year.
  • Check-Cap Ltd. reported quarterly total debt of 83 Thousand USD for 2023 Q2, down -91.56% from previous quarter.
  • Check-Cap Ltd. reported quarterly total debt of - USD for 2023 Q4, down -100.0% from previous quarter.

Annual Total Debt Chart of Check-Cap Ltd. (2023 - 2012)

Historical Annual Total Debt of Check-Cap Ltd. (2023 - 2012)

Year Total Debt Total Debt Growth
2023 - USD -100.0%
2022 964 Thousand USD -15.81%
2021 1.14 Million USD 194.34%
2020 389 Thousand USD -10.16%
2019 433 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Total Debt Comparison of Check-Cap Ltd.

Name Total Debt Total Debt Difference
Bionano Genomics, Inc. 87.94 Million USD 100.0%
Prenetics Global Limited 2.36 Million USD 100.0%
Star Equity Holdings, Inc. 3.6 Million USD 100.0%
CareDx, Inc 34.22 Million USD 100.0%
Exact Sciences Corporation 2.55 Billion USD 100.0%
Exagen Inc. 23.72 Million USD 100.0%
Inotiv, Inc. 417.64 Million USD 100.0%
Guardant Health, Inc. 1.35 Billion USD 100.0%
Biodesix, Inc. 60.69 Million USD 100.0%
BioNexus Gene Lab Corp. 133.39 Thousand USD 100.0%
Precipio, Inc. 1.11 Million USD 100.0%
iSpecimen Inc. 196.24 Thousand USD 100.0%
Natera, Inc. 441.99 Million USD 100.0%
Aspira Women's Health Inc. 2.26 Million USD 100.0%
Standard BioTools Inc. 98.21 Million USD 100.0%
23andMe Holding Co. 76.51 Million USD 100.0%
Castle Biosciences, Inc. 15.31 Million USD 100.0%
Personalis, Inc. 48.96 Million USD 100.0%
Aclaris Therapeutics, Inc. 426 Thousand USD 100.0%
Applied DNA Sciences, Inc. 1.23 Million USD 100.0%
OpGen, Inc. 13.04 Million USD 100.0%
T2 Biosystems, Inc. 49.49 Million USD 100.0%
Myriad Genetics, Inc. 145 Million USD 100.0%
ICON Public Limited Company 3.93 Billion USD 100.0%
NeoGenomics, Inc. 611.67 Million USD 100.0%
Star Equity Holdings, Inc. 3.6 Million USD 100.0%
IDEXX Laboratories, Inc. 947.88 Million USD 100.0%
RadNet, Inc. 1.49 Billion USD 100.0%
MDxHealth SA 41.26 Million USD 100.0%
Psychemedics Corporation 2.29 Million USD 100.0%
Illumina, Inc. 2.26 Billion USD 100.0%
Twist Bioscience Corporation 94.06 Million USD 100.0%
DarioHealth Corp. 29.54 Million USD 100.0%
Fulgent Genetics, Inc. 14.9 Million USD 100.0%
Sera Prognostics, Inc. 1.85 Million USD 100.0%
ENDRA Life Sciences Inc. 394.4 Thousand USD 100.0%
OPKO Health, Inc. 326.56 Million USD 100.0%
Medpace Holdings, Inc. 142.12 Million USD 100.0%
Neogen Corporation 906.23 Million USD 100.0%
Intelligent Bio Solutions Inc. 871.44 Thousand USD 100.0%
Prenetics Global Limited 2.36 Million USD 100.0%
Mainz Biomed B.V. 7.42 Million USD 100.0%
bioAffinity Technologies, Inc. 1.57 Million USD 100.0%
Trinity Biotech plc 67.42 Million USD 100.0%
Neuronetics, Inc. 62.47 Million USD 100.0%
Sotera Health Company 2.32 Billion USD 100.0%
bioAffinity Technologies, Inc. 1.57 Million USD 100.0%